Previous close | 12.78 |
Open | 12.60 |
Bid | 0.00 x 1300 |
Ask | 0.00 x 4000 |
Day's range | 12.60 - 13.20 |
52-week range | 11.44 - 19.02 |
Volume | |
Avg. volume | 2,720,131 |
Market cap | 2.993B |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.24 |
Earnings date | 21 Feb 2022 - 25 Feb 2022 |
Forward dividend & yield | 1.20 (8.92%) |
Ex-dividend date | 10 Feb 2022 |
1y target est | 15.77 |
These income stocks, with yields ranging from 7.3% to 11.6%, can make long-term investors a lot richer.
Sabra (SBRA) delivered FFO and revenue surprises of 2.63% and 1.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
IRVINE, Calif., May 04, 2022--Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2022. In addition, the Company provided a business update.